بدائل البحث:
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
small decrease » small increased (توسيع البحث)
nn decrease » a decrease (توسيع البحث), mean decrease (توسيع البحث), gy decreased (توسيع البحث)
a large » _ large (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
small decrease » small increased (توسيع البحث)
nn decrease » a decrease (توسيع البحث), mean decrease (توسيع البحث), gy decreased (توسيع البحث)
a large » _ large (توسيع البحث)
-
1
Image 6_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
2
Image 7_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
3
Image 3_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
4
Image 1_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
5
Image 2_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
6
Image 4_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
7
Image 5_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
8
Image 8_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
منشور في 2025"…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.</p>Results<p>In total, 15 types of decreased autoantibodies were identified, and 6 of them were constructed into a predictive model for early lung cancer, reaching a sensitivity of 76.19% and a specificity of 55.74%. …"
-
9
-
10
Geographical distribution of large cities and small cities.
منشور في 2024"…The Figure reveals two patterns: 1) the maximum level of innovation is higher in large cities (2.53) than in small cities (2.02); 2) among large cities in <b>a</b>, innovation levels in general decrease with nightlight density. …"
-
11
Table 6_Road transportation is associated with decreased intestinal motility in horses.docx
منشور في 2025"…</p>Results<p>After transportation, intestinal motility grades were reduced [Tpre median (IQR) composite motility grade: 8 (7-10), T1: 6 (4-7), T2: 7 (6-7); p < 0.001] and qualitative changes were observed in small intestinal sonographic appearance. …"
-
12
Sleep deprivation increased inflammatory cytokines and decreased corticosterone in the blood.
منشور في 2025الموضوعات: -
13
-
14
Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx
منشور في 2025"…However, the effect of reduced SSC on Chl-a is poorly studied. Here, we compared and analyzed the distribution conditions of Chl-a in 6 representative years for both before the implementation of Three Gorges Dam (TGD) (BIT) and after the implementation of TGD (AIT), using the TM/OLI data and NIR-red inversion model. …"
-
15
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
منشور في 2025"…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"
-
16
-
17
-
18
-
19
-
20